These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


203 related items for PubMed ID: 2161185

  • 1. Platelet activity and phosphoinositide turnover increase with advancing age.
    Bastyr EJ, Kadrofske MM, Vinik AI.
    Am J Med; 1990 Jun; 88(6):601-6. PubMed ID: 2161185
    [Abstract] [Full Text] [Related]

  • 2. Decreased platelet phosphoinositide turnover and enhanced platelet activation in IDDM.
    Bastyr EJ, Kadrofske MM, Dershimer RC, Vinik AI.
    Diabetes; 1989 Sep; 38(9):1097-102. PubMed ID: 2548908
    [Abstract] [Full Text] [Related]

  • 3. The inhibition of platelet-activating factor-induced platelet activation by oleic acid is associated with a decrease in polyphosphoinositide metabolism.
    Nunez D, Randon J, Gandhi C, Siafaka-Kapadai A, Olson MS, Hanahan DJ.
    J Biol Chem; 1990 Oct 25; 265(30):18330-8. PubMed ID: 2170407
    [Abstract] [Full Text] [Related]

  • 4. Elevation of cyclic AMP decreases phosphoinositide turnover and inhibits thrombin-induced secretion in human platelets.
    Ryningen A, Olav Jensen B, Holmsen H.
    Biochim Biophys Acta; 1998 Nov 02; 1394(2-3):235-48. PubMed ID: 9795233
    [Abstract] [Full Text] [Related]

  • 5. U73122 affects the equilibria between the phosphoinositides as well as phospholipase C activity in unstimulated and thrombin-stimulated human and rabbit platelets.
    Vickers JD.
    J Pharmacol Exp Ther; 1993 Sep 02; 266(3):1156-63. PubMed ID: 8396627
    [Abstract] [Full Text] [Related]

  • 6. Synergism between thrombin and adrenaline (epinephrine) in human platelets. Marked potentiation of inositol phospholipid metabolism.
    Steen VM, Tysnes OB, Holmsen H.
    Biochem J; 1988 Jul 15; 253(2):581-6. PubMed ID: 2845924
    [Abstract] [Full Text] [Related]

  • 7. Thrombin-induced abnormal platelet activation in spontaneously hypertensive rats is linked with phosphoinositides turnover and phosphorylation of 47,000 and 20,000 dalton proteins.
    Huzoor-Akbar, Anwer K.
    Thromb Res; 1988 Jan 01; 49(1):5-21. PubMed ID: 2831638
    [Abstract] [Full Text] [Related]

  • 8. ADP-induced changes in [32P]phosphate labeling of phosphatidylinositol-4,5-bisphosphate in washed rabbit platelets made refractory by prior ADP stimulation.
    Leung NL, Vickers JD, Kinlough-Rathbone RL, Reimers HJ, Mustard JF.
    Biochem Biophys Res Commun; 1983 Jun 15; 113(2):483-90. PubMed ID: 6307289
    [Abstract] [Full Text] [Related]

  • 9. Involvement of phosphoinositide metabolism in potentiation by adrenaline of ADP-induced aggregation of rabbit platelets.
    Lalau Keraly C, Vickers JD, Kinlough-Rathbone RL, Mustard JF.
    Biochem J; 1987 Mar 15; 242(3):841-7. PubMed ID: 3036103
    [Abstract] [Full Text] [Related]

  • 10. The decrease in phosphatidylinositol 4,5-bisphosphate in ADP-stimulated washed rabbit platelets is not primarily due to phospholipase C activation.
    Vickers JD, Kinlough-Rathbone RL, Mustard JF.
    Biochem J; 1986 Jul 15; 237(2):327-32. PubMed ID: 3026316
    [Abstract] [Full Text] [Related]

  • 11. The effect of ganodermic acid S on human platelets.
    Wang CN, Chen JC, Shiao MS, Wang CT.
    Adv Exp Med Biol; 1990 Jul 15; 281():265-9. PubMed ID: 1966354
    [Abstract] [Full Text] [Related]

  • 12. The aggregation of human platelet induced by ganodermic acid S.
    Wang CN, Chen JC, Shiao MS, Wang CT.
    Biochim Biophys Acta; 1989 Nov 17; 986(1):151-60. PubMed ID: 2819092
    [Abstract] [Full Text] [Related]

  • 13. Platelet phosphoinositide turnover in streptozotocin-induced diabetes.
    Jethmalani SM, Dang AQ, Faas FH.
    Prostaglandins Leukot Essent Fatty Acids; 1994 Jun 17; 50(6):339-46. PubMed ID: 7938087
    [Abstract] [Full Text] [Related]

  • 14. Altered platelet phosphatidylinositol metabolism in essential hypertension.
    Dimitrov D, Resink TJ, Müller FB, Bühler FR.
    J Hypertens Suppl; 1986 Dec 17; 4(6):S346-8. PubMed ID: 3039092
    [Abstract] [Full Text] [Related]

  • 15. Evidence for tight metabolic control of the receptor-activated polyphosphoinositide cycle in human platelets.
    Steen VM, Tysnes OB, Holmsen H.
    Biochem J; 1989 Oct 15; 263(2):621-4. PubMed ID: 2557003
    [Abstract] [Full Text] [Related]

  • 16. Human platelet activation by bacterial phospholipase C is mediated by phosphatidylinositol hydrolysis but not generation of phosphatidic acid: inhibition by a selective inhibitor of phospholipase C.
    Navran SS, Romstedt K, Chang J, Miller DD, Feller DR, Huzoor-Akbar.
    Thromb Res; 1984 Mar 01; 33(5):499-510. PubMed ID: 6372157
    [Abstract] [Full Text] [Related]

  • 17. The phosphoinositides exist in multiple metabolic pools in rabbit platelets.
    Vickers JD, Mustard JF.
    Biochem J; 1986 Sep 01; 238(2):411-7. PubMed ID: 3026351
    [Abstract] [Full Text] [Related]

  • 18. Chlorpromazine increases the turnover of metabolically active phosphoinositides and elevates the steady-state level of phosphatidylinositol-4-phosphate in human platelets.
    Frølich KW, Aarbakke GM, Holmsen H.
    Biochem Pharmacol; 1992 Nov 17; 44(10):2013-20. PubMed ID: 1333202
    [Abstract] [Full Text] [Related]

  • 19. Changes in phosphoinositide turnover, Ca2+ mobilization, and protein phosphorylation in platelets from NIDDM patients.
    Ishii H, Umeda F, Hashimoto T, Nawata H.
    Diabetes; 1990 Dec 17; 39(12):1561-8. PubMed ID: 2174010
    [Abstract] [Full Text] [Related]

  • 20. Inositol phospholipid metabolism in human platelets stimulated by ADP.
    Vickers JD, Kinlough-Rathbone RL, Packham MA, Mustard JF.
    Eur J Biochem; 1990 Oct 24; 193(2):521-8. PubMed ID: 2171937
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 11.